187 related articles for article (PubMed ID: 9414274)
1. Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells.
Breems DA; Blokland EA; Siebel KE; Mayen AE; Engels LJ; Ploemacher RE
Blood; 1998 Jan; 91(1):111-7. PubMed ID: 9414274
[TBL] [Abstract][Full Text] [Related]
2. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.
Kusadasi N; van Soest PL; Mayen AE; Koevoet JL; Ploemacher RE
Leukemia; 2000 Nov; 14(11):1944-53. PubMed ID: 11069030
[TBL] [Abstract][Full Text] [Related]
3. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.
Bennaceur-Griscelli A; Tourino C; Izac B; Vainchenker W; Coulombel L
Blood; 1999 Jul; 94(2):529-38. PubMed ID: 10397720
[TBL] [Abstract][Full Text] [Related]
4. Stroma-conditioned media improve expansion of human primitive hematopoietic stem cells and progenitor cells.
Breems DA; Blokland EA; Ploemacher RE
Leukemia; 1997 Jan; 11(1):142-50. PubMed ID: 9001430
[TBL] [Abstract][Full Text] [Related]
5. Individual stem cell quality in leukapheresis products is related to the number of mobilized stem cells.
Breems DA; van Hennik PB; Kusadasi N; Boudewijn A; Cornelissen JJ; Sonneveld P; Ploemacher RE
Blood; 1996 Jun; 87(12):5370-8. PubMed ID: 8652852
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
7. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood.
Tanavde VM; Malehorn MT; Lumkul R; Gao Z; Wingard J; Garrett ES; Civin CI
Exp Hematol; 2002 Jul; 30(7):816-23. PubMed ID: 12135681
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
9. Stromal support augments extended long-term ex vivo expansion of hemopoietic progenitor cells.
Kusadasi N; Koevoet JL; van Soest PL; Ploemacher RE
Leukemia; 2001 Sep; 15(9):1347-58. PubMed ID: 11516095
[TBL] [Abstract][Full Text] [Related]
10. Serum-free coculture system for ex vivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells.
Yamaguchi M; Hirayama F; Kanai M; Sato N; Fukazawa K; Yamashita K; Sawada K; Koike T; Kuwabara M; Ikeda H; Ikebuchi K
Exp Hematol; 2001 Feb; 29(2):174-82. PubMed ID: 11166456
[TBL] [Abstract][Full Text] [Related]
11. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941
[TBL] [Abstract][Full Text] [Related]
12. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.
Petzer AL; Zandstra PW; Piret JM; Eaves CJ
J Exp Med; 1996 Jun; 183(6):2551-8. PubMed ID: 8676076
[TBL] [Abstract][Full Text] [Related]
13. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice.
Herrera C; Sánchez J; Torres A; Bellido C; Rueda A; Alvarez MA
Br J Haematol; 2001 Sep; 114(4):920-30. PubMed ID: 11564087
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone.
Luens KM; Travis MA; Chen BP; Hill BL; Scollay R; Murray LJ
Blood; 1998 Feb; 91(4):1206-15. PubMed ID: 9454750
[TBL] [Abstract][Full Text] [Related]
16. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
17. Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells.
Scheding S; Meister B; Bühring HJ; Baum CM; Mc Kearn JP; Bock T; Kanz L; Brugger W
Exp Hematol; 2000 Apr; 28(4):460-70. PubMed ID: 10781904
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability.
Tisdale JF; Hanazono Y; Sellers SE; Agricola BA; Metzger ME; Donahue RE; Dunbar CE
Blood; 1998 Aug; 92(4):1131-41. PubMed ID: 9694700
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
Grassinger J; Mueller G; Zaiss M; Kunz-Schughart LA; Andreesen R; Hennemann B
Eur J Haematol; 2006 Aug; 77(2):134-44. PubMed ID: 16856909
[TBL] [Abstract][Full Text] [Related]
20. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.
Young JC; Lin K; Hansteen G; Travis M; Murray LJ; Jaing L; Scollay R; Hill BL
Exp Hematol; 1999 Jun; 27(6):994-1003. PubMed ID: 10378888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]